Skip to main content

MMSI Merit Medical Systems, Inc.

Healthcare

84.16 USD 1D -0.15 -0.18% Close 11/3
Since 2024-12-03 -19.6%
Open
84.04
High
85.06
Low
83.65
Prev close
84.31
Volume
797.1K
Amplitude
1.67%
P/E
31.7
P/B
2.9
Revenue YoY (TTM)
+9.1%
52W 59.74 94.85

Is Merit Medical Systems, Inc. a buy? Fundamentals and valuation first

As of 2026-11-02

Quality: Good, Growth: Good, Risk / liquidity: Good; Valuation: Pricey.

Valuation Pricey Free-cash-flow yield is Good, but Price / book is Pricey.
TTM P/E 31.7 70th percentile Pricey
Price / book 2.9 70th percentile Pricey
Free-cash-flow yield (%) 4.06 63th percentile Good
US Stock Backtest in Python: Price-to-Book Ratio StrategyQuality Factor Investing: A US Quality Value Backtest
Quality Good All 3 indicators are Good.
ROE, TTM (%) 9.18 63th percentile Good
Operating margin, TTM (%) 13.46 62th percentile Good
FCF margin, TTM (%) 12.72 66th percentile Good
Quality Factor Investing: A US Quality Value Backtest
Growth Good All 2 indicators are Good.
Revenue growth, TTM YoY (%) 9.11 59th percentile Good
Diluted EPS growth, TTM YoY (%) 36.41 73th percentile Good
Momentum Neutral 60-day return is Good, but 240-day return is Average.
60-day return (%) -5.31 54th percentile Good
240-day return (%) -1.73 47th percentile Average
Momentum Trading Strategy: A 12-1 Momentum Backtest
Risk / liquidity Good 20-day dollar volume is Top; 60-day annualized volatility is Good.
20-day dollar volume 65,098,169 83th percentile Top
60-day annualized volatility (%) 26.27 29th percentile Good
Factor Investing Explained: 10 Classic Factors in US Stocks

Merit Medical Systems, Inc. (MMSI) today

2 quant signals active · As of 2026-11-02

Win rate and excess are historical post-trigger stats vs the market. Click a signal for its full definition and samples; history does not predict future results.

FinLab Studio

From Merit Medical Systems, Inc. to every stock like it

AI finds several complementary traits of Merit Medical Systems, Inc. across different dimensions, combines them into a multifactor strategy, and backtests it against the market.

Screen stocks like Merit Medical Systems, Inc.

Merit Medical Systems, Inc. (MMSI) peers and tracking

Watchlist

This page refreshes daily after the close. Add Merit Medical Systems, Inc. to your watchlist to track signal changes on your next visit.

Merit Medical Systems, Inc. (MMSI) quant signal backtests

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

Top-quintile 6-month momentum

Active · now 86.47%

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

Momentum Trading Strategy: A 12-1 Momentum Backtest
25 historical occurrences (since 2016-07-27)

Average forward return after Top-quintile 6-month momentum

20-day: Win 58.3%, Sample 24, Median +1.04%, Excess +0.37%, Beat mkt rate 58.3%

60-day: Win 79.2%, Sample 24, Median +8.8%, Excess +3.99%, Beat mkt rate 70.8%

120-day: Win 79.2%, Sample 24, Median +16.81%, Excess +8.55%, Beat mkt rate 75%

120 days after: historical avg +14.74%

20-day +0.78%
60-day +7.65%
120-day +14.74%
20-day
60-day
120-day
Win
58.3%
79.2%
79.2%
Sample
24
24
24
Median
+1.04%
+8.8%
+16.81%
Excess
+0.37%
+3.99%
+8.55%
Beat mkt rate
58.3%
70.8%
75%

Over 24 occurrences, 120-day forward avg gained 14.74%, beat the market by 8.55 pts; win rate 79.2%.

EPS surprise beat

Active · now 7.69%

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

PEAD: Post-Earnings Announcement Drift Backtest
41 historical occurrences (since 2015-02-24)

Average forward return after EPS surprise beat

20-day: Win 73%, Sample 37, Median +4.3%, Excess +1.46%, Beat mkt rate 64.9%

60-day: Win 73%, Sample 37, Median +8.1%, Excess +1.87%, Beat mkt rate 62.2%

120-day: Win 66.7%, Sample 36, Median +11.9%, Excess +2.47%, Beat mkt rate 63.9%

120 days after: historical avg +10.24%

20-day +2.58%
60-day +5.53%
120-day +10.24%
20-day
60-day
120-day
Win
73%
73%
66.7%
Sample
37
37
36
Median
+4.3%
+8.1%
+11.9%
Excess
+1.46%
+1.87%
+2.47%
Beat mkt rate
64.9%
62.2%
63.9%

Over 36 occurrences, 120-day forward avg gained 10.24%, beat the market by 2.47 pts; win rate 66.7%.

Valuation regime and forward returns

Daily TTM P/E is converted into an expanding own-history percentile, then grouped into five valuation regimes. Forward returns use adjusted prices over the next 240 trading days.

PE percentile bandSample days240-day avg returnMedianWin rateAvg excess (vs index)
0-20 You are here666+10.3% +9.1% 63.1% -9%
20-40 248+4.1% +0.4% 50.4% -7.3%
40-60 80+13.2% +12.7% 100% +24.5%
60-80 84-12.1% -15.4% 9.5% -0.8%
80-100 116+33.4% +8.1% 60.3% +9.1%

Quarterly EPS is aligned by SEC filing date before it is forward-filled to daily prices. The expanding percentile uses only information available up to each day.

Current TTM P/E is about 31.70, placing it in the 2.6 own-history percentile, inside the 0-20 bucket.

More history: Valuation × momentum analogs, Market-wide momentum baseline, Signals not active now

Valuation × momentum analogs

Each historical day is grouped by own-history P/E tercile and 60-day momentum direction, then tested for the next 120-trading-day adjusted return.

Valuation
Momentum
Cheap (own-history bottom third)
Middle
Expensive (own-history top third)
60-day momentum up
+4.1%
Win rate 57.6% Excess -3.1%
564d
-9.9%
Win rate 6.1% Excess +2.2%
49d
+13.7%
Win rate 46.6% Excess -0.3%
146d
60-day momentum down
Now
+6.2%
Win rate 53.5% Excess -3.8%
434d
-4.4%
Win rate 25% Excess +7.7%
80d
+87.6%
Win rate 94.4% Excess +36.5%
36d

Currently in “Cheap (own-history bottom third) × 60-day momentum down”: across 434 historical days, 120-day forward avg gained 6.2%, win rate 53.5%, lagged the market by 3.8%.

Days = trading days in this bucket; returns use adjusted prices, ex-costs. 60-day momentum: direction of this stock's price over the past 60 trading days.

Market-wide momentum baseline

Across 99,771 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.43%, a 58.5% positive-return rate, and +3.08 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

52-week adjusted-price high

Pending

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

23 times historically; 60-day forward avg +5.84%, win rate 68.2%, beating the market by +1.84 pts on average.

Filed revenue acceleration

Pending

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

7 times historically; 60-day forward avg -7.5%, win rate 14.3%, beating the market by -8.43 pts on average.

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.